These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22074639)

  • 21. Testosterone in men with advanced liver disease: abnormalities and implications.
    Sinclair M; Grossmann M; Gow PJ; Angus PW
    J Gastroenterol Hepatol; 2015 Feb; 30(2):244-51. PubMed ID: 25087838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Scrotal testosterone patches: a good addition to therapeutic options for hypogonadal men].
    Asscheman H; Gooren LJ
    Ned Tijdschr Geneeskd; 2000 Apr; 144(18):847-50. PubMed ID: 10816775
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of testosterone and venesection on spinal and peripheral bone mineral in six hypogonadal men with hemochromatosis.
    Diamond T; Stiel D; Posen S
    J Bone Miner Res; 1991 Jan; 6(1):39-43. PubMed ID: 2048430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
    Miner M; Canty DJ; Shabsigh R
    Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased incidence of diagnosed depressive illness in hypogonadal older men.
    Shores MM; Sloan KL; Matsumoto AM; Moceri VM; Felker B; Kivlahan DR
    Arch Gen Psychiatry; 2004 Feb; 61(2):162-7. PubMed ID: 14757592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of testosterone gel in the treatment of erectile dysfunction in hypogonadal hemodialysis patients: a pilot study.
    Cangüven O; Aykose G; Albayrak S; Goktas C; Horuz R; Yencilek F
    Int J Impot Res; 2010; 22(2):140-5. PubMed ID: 19924130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction.
    Mulhall JP; Valenzuela R; Aviv N; Parker M
    Urology; 2004 Feb; 63(2):348-52; discussion 352-3. PubMed ID: 14972487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel testosterone 2% gel for the treatment of hypogonadal males.
    Dobs AS; McGettigan J; Norwood P; Howell J; Waldie E; Chen Y
    J Androl; 2012; 33(4):601-7. PubMed ID: 21979302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transdermal testosterone treatment of hypogonadal men.
    Carey PO; Howards SS; Vance ML
    J Urol; 1988 Jul; 140(1):76-9. PubMed ID: 3379703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body composition, metabolic syndrome and type 2 diabetes in Klinefelter syndrome.
    Gravholt CH; Jensen AS; Høst C; Bojesen A
    Acta Paediatr; 2011 Jun; 100(6):871-7. PubMed ID: 21342256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteoporosis in male hypogonadism: responses to androgen substitution differ among men with primary and secondary hypogonadism.
    Schubert M; Bullmann C; Minnemann T; Reiners C; Krone W; Jockenhövel F
    Horm Res; 2003; 60(1):21-8. PubMed ID: 12792150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone replacement increases fat-free mass and muscle size in hypogonadal men.
    Bhasin S; Storer TW; Berman N; Yarasheski KE; Clevenger B; Phillips J; Lee WP; Bunnell TJ; Casaburi R
    J Clin Endocrinol Metab; 1997 Feb; 82(2):407-13. PubMed ID: 9024227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety study of 1.62% testosterone gel for the treatment of hypogonadal men.
    Kaufman JM; Miller MG; Garwin JL; Fitzpatrick S; McWhirter C; Brennan JJ
    J Sex Med; 2011 Jul; 8(7):2079-89. PubMed ID: 21492400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel testosterone gel formulation normalizes androgen levels in hypogonadal men, with improvements in body composition and sexual function.
    McNicholas TA; Dean JD; Mulder H; Carnegie C; Jones NA
    BJU Int; 2003 Jan; 91(1):69-74. PubMed ID: 12614254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of testosterone replacement on trabecular architecture in hypogonadal men.
    Benito M; Vasilic B; Wehrli FW; Bunker B; Wald M; Gomberg B; Wright AC; Zemel B; Cucchiara A; Snyder PJ
    J Bone Miner Res; 2005 Oct; 20(10):1785-91. PubMed ID: 16160736
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using quantitative CT to assess adipose distribution in adult men with acquired hypogonadism.
    Katznelson L; Rosenthal DI; Rosol MS; Anderson EJ; Hayden DL; Schoenfeld DA; Klibanski A
    AJR Am J Roentgenol; 1998 Feb; 170(2):423-7. PubMed ID: 9456958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men--a clinical research center study.
    Brodsky IG; Balagopal P; Nair KS
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3469-75. PubMed ID: 8855787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypogonadism associated with muscle atrophy, physical inactivity and ESA hyporesponsiveness in men undergoing haemodialysis.
    Cobo G; Gallar P; Di Gioia C; García Lacalle C; Camacho R; Rodriguez I; Ortega O; Mon C; Vigil A; Lindholm B; Carrero JJ
    Nefrologia; 2017; 37(1):54-60. PubMed ID: 27553987
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A practical guide to male hypogonadism in the primary care setting.
    Dandona P; Rosenberg MT
    Int J Clin Pract; 2010 May; 64(6):682-96. PubMed ID: 20518947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prospective study of topical testosterone gel (AndroGel) versus intramuscular testosterone in testosterone-deficient HIV-infected men.
    Scott JD; Wolfe PR; Anderson P; Cohan GR; Scarsella A
    HIV Clin Trials; 2007; 8(6):412-20. PubMed ID: 18042506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.